Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Birchmeier-Kohler, Carmen Prof. Dr. (1) Chen, Wei Prof. Dr. (1) Daumke, Oliver Prof. Dr. (1) Hinz, Michael Dr. (2) Mathas, Stephan Dr. (13) Rocks, Oliver Dr. (1) Scheidereit, Claus Prof. Dr. (4) Wolf, Jana Prof. Dr. (1) Wollert-Wulf, Brigitte (4) (-) Daniel, Peter Prof. Dr. (1) (-) Janz, Martin Dr. (8) (-) Lusatis, Simone (1) (-) Selbach, Matthias Prof. Dr. (12) 1999 (3) 2000 (1) 2001 (3) (-) 2002 (4) 2003 (4) 2004 (4) 2005 (6) (-) 2006 (6) 2007 (3) 2008 (5) 2009 (9) (-) 2010 (4) 2011 (11) 2012 (6) (-) 2013 (6) 2014 (13) 2015 (12) 2016 (9) 2017 (9) 2018 (7) 2019 (5) 2020 (10) 2021 (15) 2022 (14) 2023 (10) 2024 (3) (-) Biology of Malignant Lymphomas (8) Developmental Biology / Signal Transduction (1) Genetics and Genomics of Cardiovascular Diseases (1) Mathematical Modelling of Cellular Processes (1) Molecular Immunology and Gene Therapy (1) (-) Proteome Dynamics (12) Translational Oncology of Solid Tumors (1) 20 Results: Active Filter: Daniel, Peter Prof. Dr.Janz, Martin Dr.Lusatis, SimoneSelbach, Matthias Prof. Dr.Biology of Malignant LymphomasProteome Dynamics2002200620102013 Sort: Result score Newest to oldest Oldest to newest January 01, 2002 / Int J Cancer Y-box factor YB-1 predicts drug resistance and patient outcome in breast cancer independent of clinically relevant tumor biologic factors HER2, uPA and PAI-1 M. Janz N. Harbeck P. Dettmar U. Berger A. Schmidt K. Juerchott M. Schmitt H.D. Royer April 01, 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel February 01, 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken May 15, 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas March 15, 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou March 16, 2006 / Nature Robust Salmonella metabolism limits possibilities for new antimicrobials D. Becker M. Selbach C. Rollenhagen M. Ballmaier T.F. Meyer M. Mann D. Bumann March 01, 2002 / J Biol Chem Src is the kinase of the Helicobacter pylori CagA protein in vitro and in vivo M. Selbach S. Moese C.R. Hauck T.F. Meyer S. Backert February 01, 2002 / Infect Immun Functional analysis of the Helicobacter pylori cag pathogenicity island reveals both VirD4-CagA-dependent and VirD4-CagA-independent mechanisms M. Selbach S. Moese T.F. Meyer S. Backert August 01, 2002 / Infect Immun cag+ Helicobacter pylori induces homotypic aggregation of macrophage-like cells by up-regulation and recruitment of intracellular adhesion molecule 1 to the cell surface S. Moese M. Selbach T.F. Meyer S. Backert December 01, 2006 / Nat Methods Protein interaction screening by quantitative immunoprecipitation combined with knockdown (QUICK) M. Selbach M. Mann Pagination Current page 1 Page 2 Next page Next › Last page Last »
January 01, 2002 / Int J Cancer Y-box factor YB-1 predicts drug resistance and patient outcome in breast cancer independent of clinically relevant tumor biologic factors HER2, uPA and PAI-1 M. Janz N. Harbeck P. Dettmar U. Berger A. Schmidt K. Juerchott M. Schmitt H.D. Royer
April 01, 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
February 01, 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
May 15, 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
March 15, 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
March 16, 2006 / Nature Robust Salmonella metabolism limits possibilities for new antimicrobials D. Becker M. Selbach C. Rollenhagen M. Ballmaier T.F. Meyer M. Mann D. Bumann
March 01, 2002 / J Biol Chem Src is the kinase of the Helicobacter pylori CagA protein in vitro and in vivo M. Selbach S. Moese C.R. Hauck T.F. Meyer S. Backert
February 01, 2002 / Infect Immun Functional analysis of the Helicobacter pylori cag pathogenicity island reveals both VirD4-CagA-dependent and VirD4-CagA-independent mechanisms M. Selbach S. Moese T.F. Meyer S. Backert
August 01, 2002 / Infect Immun cag+ Helicobacter pylori induces homotypic aggregation of macrophage-like cells by up-regulation and recruitment of intracellular adhesion molecule 1 to the cell surface S. Moese M. Selbach T.F. Meyer S. Backert
December 01, 2006 / Nat Methods Protein interaction screening by quantitative immunoprecipitation combined with knockdown (QUICK) M. Selbach M. Mann